The World Health Organisation has listed the first mpox in vitro diagnostic test under its Emergency Use Listing procedure, marking an important step in improving global access to mpox testing.
In a statement released on Thursday, WHO announced that the emergency use approval of the Alinity m MPXV assay, manufactured by Abbott Molecular Inc., will be crucial in expanding diagnostic capacity in countries experiencing mpox outbreaks, where the…
Read the full article here